0000950170-23-049302.txt : 20230921 0000950170-23-049302.hdr.sgml : 20230921 20230921214018 ACCESSION NUMBER: 0000950170-23-049302 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230920 FILED AS OF DATE: 20230921 DATE AS OF CHANGE: 20230921 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Medpace Investors, LLC CENTRAL INDEX KEY: 0001524599 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37856 FILM NUMBER: 231270136 BUSINESS ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 BUSINESS PHONE: 513-579-9911 MAIL ADDRESS: STREET 1: 4620 WESLEY AVENUE CITY: CINCINNATI STATE: OH ZIP: 45212 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Medpace Holdings, Inc. CENTRAL INDEX KEY: 0001668397 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 320434904 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 BUSINESS PHONE: (513) 579-9911 MAIL ADDRESS: STREET 1: 5375 MEDPACE WAY CITY: CINCINNATI STATE: OH ZIP: 45227 4 1 ownership.xml 4 X0508 4 2023-09-20 0001668397 Medpace Holdings, Inc. MEDP 0001524599 Medpace Investors, LLC C/O MEDPACE HOLDINGS, INC. 5375 MEDPACE WAY CINCINNATI OH 45227 false false true false true Common Stock 2023-09-20 4 S false 65653 255.48 D 5976602 D Common Stock 2023-09-21 4 S false 61655 244.27 D 5914947 D The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 1. 2023. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $253.07 to $257.935. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $239.77 to $251.58. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request. /s/ Stephen P. Ewald, Attorney-in-Fact for Medpace Investors, LLC 2023-09-21